Global Transmucosal Drug Delivery Market 2020 by Company, Type and Application, Forecast to 2025

  • receipt Report ID : 67393
  • calendar_today Published On: May, 2020
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Market Overview

The global Transmucosal Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Transmucosal Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Transmucosal Drug Delivery market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Transmucosal Drug Delivery market has been segmented into Passive Transdermal Drug Delivery, Active Transdermal Drug Delivery, etc.

Breakdown by Application, Transmucosal Drug Delivery has been segmented into Hospital, Clinic, Others, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Transmucosal Drug Delivery market presented in the report. This section sheds light on the sales growth of different regional and country-level Transmucosal Drug Delivery markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Transmucosal Drug Delivery market.

For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Transmucosal Drug Delivery Market Share Analysis

Transmucosal Drug Delivery competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Transmucosal Drug Delivery revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Transmucosal Drug Delivery revenue and market share for each player covered in this report.

The major players covered in Transmucosal Drug Delivery are: 3M Pharmaceuticals, DURECT Corporation, Antares Pharma, Inc., Acrux Limited, Corium International, Inc, ALZA Corporation, Inovio Pharmaceuticals, Inc., Aveva Drug Delivery Systems, Apricus BioSciences, Inc, Generex Biotechnology Corporation, Nitto Denko Corporation, Tapemark, Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG), TEVA Pharmaceutical Industries Ltd., Noven Pharmaceuticals, Inc., Nemaura Pharma Ltd, MedPharm LTD, tesa Labtec GmbH, Pantec Biosolutions AG, Mylan, Inc., Zosano Pharma, etc. Among other players domestic and global, Transmucosal Drug Delivery market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers

3M Pharmaceuticals

DURECT Corporation

Antares Pharma, Inc.

Acrux Limited

Corium International, Inc

ALZA Corporation

Inovio Pharmaceuticals, Inc.

Aveva Drug Delivery Systems

Apricus BioSciences, Inc

Generex Biotechnology Corporation

Nitto Denko Corporation

Tapemark

Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)

TEVA Pharmaceutical Industries Ltd.

Noven Pharmaceuticals, Inc.

Nemaura Pharma Ltd

MedPharm LTD

tesa Labtec GmbH

Pantec Biosolutions AG

Mylan, Inc.

Zosano Pharma

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina)

MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:

Passive Transdermal Drug Delivery

Active Transdermal Drug Delivery

Market segment by Application, can be divided into

Hospital

Clinic

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Product Overview and Scope of Transmucosal Drug Delivery

1.2 Classification of Transmucosal Drug Delivery by Type

1.2.1 Overview: Global Transmucosal Drug Delivery Revenue by Type: 2015 Versus 2019 Versus 2025

1.2.2 Global Transmucosal Drug Delivery Revenue Market Share by Type in 2019

1.2.3 Passive Transdermal Drug Delivery

1.2.4 Active Transdermal Drug Delivery

1.3 Global Transmucosal Drug Delivery Market by Application

1.3.1 Overview: Global Transmucosal Drug Delivery Revenue by Application: 2015 Versus 2019 Versus 2025

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

1.5 Global Transmucosal Drug Delivery Market Size by Regions: 2015 VS 2019 VS 2025

1.6 Global Transmucosal Drug Delivery Market Size by Regions (2015-2020)

1.7 Global Transmucosal Drug Delivery Market Size and Forecast by Regions (2020-2025)

1.7.1 North America Transmucosal Drug Delivery Status and Prospect (2015-2025)

1.7.2 Europe Transmucosal Drug Delivery Status and Prospect (2015-2025)

1.7.3 Asia Transmucosal Drug Delivery Status and Prospect (2015-2025)

1.7.4 South America Transmucosal Drug Delivery Status and Prospect (2015-2025)

1.7.5 Middle East & Africa Transmucosal Drug Delivery Status and Prospect (2015-2025)

2 Company Profiles

2.1 3M Pharmaceuticals

2.1.1 3M Pharmaceuticals Details

2.1.2 3M Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 3M Pharmaceuticals SWOT Analysis

2.1.4 3M Pharmaceuticals Product and Services

2.1.5 3M Pharmaceuticals Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.2 DURECT Corporation

2.2.1 DURECT Corporation Details

2.2.2 DURECT Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 DURECT Corporation SWOT Analysis

2.2.4 DURECT Corporation Product and Services

2.2.5 DURECT Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.3 Antares Pharma, Inc.

2.3.1 Antares Pharma, Inc. Details

2.3.2 Antares Pharma, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Antares Pharma, Inc. SWOT Analysis

2.3.4 Antares Pharma, Inc. Product and Services

2.3.5 Antares Pharma, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.4 Acrux Limited

2.4.1 Acrux Limited Details

2.4.2 Acrux Limited Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Acrux Limited SWOT Analysis

2.4.4 Acrux Limited Product and Services

2.4.5 Acrux Limited Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.5 Corium International, Inc

2.5.1 Corium International, Inc Details

2.5.2 Corium International, Inc Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Corium International, Inc SWOT Analysis

2.5.4 Corium International, Inc Product and Services

2.5.5 Corium International, Inc Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.6 ALZA Corporation

2.6.1 ALZA Corporation Details

2.6.2 ALZA Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 ALZA Corporation SWOT Analysis

2.6.4 ALZA Corporation Product and Services

2.6.5 ALZA Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.7 Inovio Pharmaceuticals, Inc.

2.7.1 Inovio Pharmaceuticals, Inc. Details

2.7.2 Inovio Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Inovio Pharmaceuticals, Inc. SWOT Analysis

2.7.4 Inovio Pharmaceuticals, Inc. Product and Services

2.7.5 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.8 Aveva Drug Delivery Systems

2.8.1 Aveva Drug Delivery Systems Details

2.8.2 Aveva Drug Delivery Systems Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Aveva Drug Delivery Systems SWOT Analysis

2.8.4 Aveva Drug Delivery Systems Product and Services

2.8.5 Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.9 Apricus BioSciences, Inc

2.9.1 Apricus BioSciences, Inc Details

2.9.2 Apricus BioSciences, Inc Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Apricus BioSciences, Inc SWOT Analysis

2.9.4 Apricus BioSciences, Inc Product and Services

2.9.5 Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.10 Generex Biotechnology Corporation

2.10.1 Generex Biotechnology Corporation Details

2.10.2 Generex Biotechnology Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Generex Biotechnology Corporation SWOT Analysis

2.10.4 Generex Biotechnology Corporation Product and Services

2.10.5 Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.11 Nitto Denko Corporation

2.11.1 Nitto Denko Corporation Details

2.11.2 Nitto Denko Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 Nitto Denko Corporation SWOT Analysis

2.11.4 Nitto Denko Corporation Product and Services

2.11.5 Nitto Denko Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.12 Tapemark

2.12.1 Tapemark Details

2.12.2 Tapemark Major Business and Total Revenue (Financial Highlights) Analysis

2.12.3 Tapemark SWOT Analysis

2.12.4 Tapemark Product and Services

2.12.5 Tapemark Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.13 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)

2.13.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Details

2.13.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Major Business and Total Revenue (Financial Highlights) Analysis

2.13.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) SWOT Analysis

2.13.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Product and Services

2.13.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.14 TEVA Pharmaceutical Industries Ltd.

2.14.1 TEVA Pharmaceutical Industries Ltd. Details

2.14.2 TEVA Pharmaceutical Industries Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.14.3 TEVA Pharmaceutical Industries Ltd. SWOT Analysis

2.14.4 TEVA Pharmaceutical Industries Ltd. Product and Services

2.14.5 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.15 Noven Pharmaceuticals, Inc.

2.15.1 Noven Pharmaceuticals, Inc. Details

2.15.2 Noven Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.15.3 Noven Pharmaceuticals, Inc. SWOT Analysis

2.15.4 Noven Pharmaceuticals, Inc. Product and Services

2.15.5 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.16 Nemaura Pharma Ltd

2.16.1 Nemaura Pharma Ltd Details

2.16.2 Nemaura Pharma Ltd Major Business and Total Revenue (Financial Highlights) Analysis

2.16.3 Nemaura Pharma Ltd SWOT Analysis

2.16.4 Nemaura Pharma Ltd Product and Services

2.16.5 Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.17 MedPharm LTD

2.17.1 MedPharm LTD Details

2.17.2 MedPharm LTD Major Business and Total Revenue (Financial Highlights) Analysis

2.17.3 MedPharm LTD SWOT Analysis

2.17.4 MedPharm LTD Product and Services

2.17.5 MedPharm LTD Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.18 tesa Labtec GmbH

2.18.1 tesa Labtec GmbH Details

2.18.2 tesa Labtec GmbH Major Business and Total Revenue (Financial Highlights) Analysis

2.18.3 tesa Labtec GmbH SWOT Analysis

2.18.4 tesa Labtec GmbH Product and Services

2.18.3 tesa Labtec GmbH Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.19 Pantec Biosolutions AG

2.19.1 Pantec Biosolutions AG Details

2.19.2 Pantec Biosolutions AG Major Business and Total Revenue (Financial Highlights) Analysis

2.19.3 Pantec Biosolutions AG SWOT Analysis

2.19.4 Pantec Biosolutions AG Product and Services

2.19.5 Pantec Biosolutions AG Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.20 Mylan, Inc.

2.20.1 Mylan, Inc. Details

2.20.2 Mylan, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.20.3 Mylan, Inc. SWOT Analysis

2.20.4 Mylan, Inc. Product and Services

2.20.5 Mylan, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

2.21 Zosano Pharma

2.21.1 Zosano Pharma Details

2.21.2 Zosano Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.21.3 Zosano Pharma SWOT Analysis

2.21.4 Zosano Pharma Product and Services

2.21.5 Zosano Pharma Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Transmucosal Drug Delivery Market Size by Players (2015-2020)

3.2 China Transmucosal Drug Delivery Market Size by Players (2015-2020)

3.3 Market Concentration Rate

3.3.1 Top 5 Transmucosal Drug Delivery Players Market Share

3.3.2 Top 10 Transmucosal Drug Delivery Players Market Share

4 North America Market Size and Forecast by Countries

4.1 North America Transmucosal Drug Delivery Market Size by Countries (2015-2020)

4.2 North America Transmucosal Drug Delivery Market Size and Forecast by Countries (2015-2026)

4.3 United States Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

4.4 Canada Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

4.5 Mexico Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries

5.1 Europe Transmucosal Drug Delivery Market Size by Countries (2015-2020)

5.2 Europe Transmucosal Drug Delivery Market Size and Forecast by Countries (2015-2026)

5.3 Germany Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

5.4 France Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

5.5 UK Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

5.6 Russia Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

5.7 Italy Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries

6.1 Asia-Pacific Transmucosal Drug Delivery Market Size by Regions (2015-2020)

6.2 Asia-Pacific Transmucosal Drug Delivery Market Size and Forecast by Regions (2015-2026)

6.3 China Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

6.4 Japan Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

6.5 Korea Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

6.6 India Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

6.7 Southeast Asia Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries

7.1 South America Transmucosal Drug Delivery Market Size by Countries (2015-2020)

7.2 South America Transmucosal Drug Delivery Market Size and Forecast by Countries (2015-2026)

7.3 Brazil Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

7.4 Argentina Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries

8.1 Middle East & Africa Transmucosal Drug Delivery Revenue by Regions (2015-2020)

8.2 Middle East & Africa Transmucosal Drug Delivery Market Size and Forecast by Countries (2015-2026)

8.3 Saudi Arabia Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

8.4 UAE Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

8.5 Egypt Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

8.6 South Africa Transmucosal Drug Delivery Market Size and Forecast (2015-2025)

9 Market Size Segment by Type

9.1 Global Transmucosal Drug Delivery Market Size and Forecast by Type (2015-2025)

9.1.1 Global Transmucosal Drug Delivery Market Size by Type (2015-2020)

9.1.2 Global Transmucosal Drug Delivery Market Size Forecast by Type (2020-2025)

9.2 China Transmucosal Drug Delivery Market Size and Forecast by Type (2015-2025)

9.2.1 China Transmucosal Drug Delivery Market Size by Type (2015-2020)

9.2.2 China Transmucosal Drug Delivery Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application

10.1 Global Transmucosal Drug Delivery Market Size and Forecast by Application (2015-2025)

10.1.1 Global Transmucosal Drug Delivery Market Size by Application (2015-2020)

10.1.2 Global Transmucosal Drug Delivery Market Size Forecast by Application (2020-2025)

10.2 China Transmucosal Drug Delivery Market Size and Forecast by Application (2015-2025)

10.2.1 China Transmucosal Drug Delivery Market Size by Application (2015-2020)

10.2.2 China Transmucosal Drug Delivery Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Data Source

12.3 Disclaimer

12.4 About US

List of Tables

Table 1. Global Transmucosal Drug Delivery Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025

Table 2. Breakdown of Transmucosal Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Transmucosal Drug Delivery Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025

Table 4. Global Market Transmucosal Drug Delivery Market Size (USD Million) Comparison by Regions (2020-2025)

Table 5. Global Transmucosal Drug Delivery Revenue (USD Million) by Regions (2015-2020)

Table 6. Global Transmucosal Drug Delivery Revenue Share by Regions (2015-2020)

Table 7. Global Transmucosal Drug Delivery Revenue (USD Million) by Regions (2020-2025)

Table 8. Global Transmucosal Drug Delivery Revenue Market Share by Regions (2020-2025)

Table 9. 3M Pharmaceuticals Corporate Information, Location and Competitors

Table 10. 3M Pharmaceuticals Major Business

Table 11. 3M Pharmaceuticals Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 12. 3M Pharmaceuticals SWOT Analysis

Table 13. 3M Pharmaceuticals Transmucosal Drug Delivery Product and Solutions

Table 14. 3M Pharmaceuticals Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 15. DURECT Corporation Corporate Information, Location and Competitors

Table 16. DURECT Corporation Major Business

Table 17. DURECT Corporation Transmucosal Drug Delivery Total Revenue (USD Million) (2018-2019)

Table 18. DURECT Corporation SWOT Analysis

Table 19. DURECT Corporation Transmucosal Drug Delivery Product and Solutions

Table 20. DURECT Corporation Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 21. Antares Pharma, Inc. Corporate Information, Location and Competitors

Table 22. Antares Pharma, Inc. Major Business

Table 23. Antares Pharma, Inc. Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 24. Antares Pharma, Inc. SWOT Analysis

Table 25. Antares Pharma, Inc. Transmucosal Drug Delivery Product and Solutions

Table 26. Antares Pharma, Inc. Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 27. Acrux Limited Corporate Information, Location and Competitors

Table 28. Acrux Limited Major Business

Table 29. Acrux Limited Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 30. Acrux Limited SWOT Analysis

Table 31. Acrux Limited Transmucosal Drug Delivery Product and Solutions

Table 32. Acrux Limited Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 33. Corium International, Inc Corporate Information, Location and Competitors

Table 34. Corium International, Inc Major Business

Table 35. Corium International, Inc Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 36. Corium International, Inc SWOT Analysis

Table 37. Corium International, Inc Transmucosal Drug Delivery Product and Solutions

Table 38. Corium International, Inc Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 39. ALZA Corporation Corporate Information, Location and Competitors

Table 40. ALZA Corporation Major Business

Table 41. ALZA Corporation Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 42. ALZA Corporation SWOT Analysis

Table 43. ALZA Corporation Transmucosal Drug Delivery Product and Solutions

Table 44. ALZA Corporation Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 45. Inovio Pharmaceuticals, Inc. Corporate Information, Location and Competitors

Table 46. Inovio Pharmaceuticals, Inc. Major Business

Table 47. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 48. Inovio Pharmaceuticals, Inc. SWOT Analysis

Table 49. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product and Solutions

Table 50. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 51. Aveva Drug Delivery Systems Corporate Information, Location and Competitors

Table 52. Aveva Drug Delivery Systems Major Business

Table 53. Aveva Drug Delivery Systems Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 54. Aveva Drug Delivery Systems SWOT Analysis

Table 55. Aveva Drug Delivery Systems Transmucosal Drug Delivery Product and Solutions

Table 56. Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 57. Apricus BioSciences, Inc Corporate Information, Location and Competitors

Table 58. Apricus BioSciences, Inc Major Business

Table 59. Apricus BioSciences, Inc Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 60. Apricus BioSciences, Inc SWOT Analysis

Table 61. Apricus BioSciences, Inc Transmucosal Drug Delivery Product and Solutions

Table 62. Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 63. Generex Biotechnology Corporation Corporate Information, Location and Competitors

Table 64. Generex Biotechnology Corporation Major Business

Table 65. Generex Biotechnology Corporation Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 66. Generex Biotechnology Corporation SWOT Analysis

Table 67. Generex Biotechnology Corporation Transmucosal Drug Delivery Product and Solutions

Table 68. Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 69. Nitto Denko Corporation Corporate Information, Location and Competitors

Table 70. Nitto Denko Corporation Major Business

Table 71. Nitto Denko Corporation Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 72. Nitto Denko Corporation SWOT Analysis

Table 73. Nitto Denko Corporation Transmucosal Drug Delivery Product and Solutions

Table 74. Nitto Denko Corporation Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 75. Tapemark Corporate Information, Location and Competitors

Table 76. Tapemark Major Business

Table 77. Tapemark Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 78. Tapemark SWOT Analysis

Table 79. Tapemark Transmucosal Drug Delivery Product and Solutions

Table 80. Tapemark Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 81. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Corporate Information, Location and Competitors

Table 82. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Major Business

Table 83. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 84. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) SWOT Analysis

Table 85. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product and Solutions

Table 86. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 87. TEVA Pharmaceutical Industries Ltd. Corporate Information, Location and Competitors

Table 88. TEVA Pharmaceutical Industries Ltd. Major Business

Table 89. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 90. TEVA Pharmaceutical Industries Ltd. SWOT Analysis

Table 91. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Product and Solutions

Table 92. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 93. Noven Pharmaceuticals, Inc. Corporate Information, Location and Competitors

Table 94. Noven Pharmaceuticals, Inc. Major Business

Table 95. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 96. Noven Pharmaceuticals, Inc. SWOT Analysis

Table 97. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Product and Solutions

Table 98. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 99. Nemaura Pharma Ltd Corporate Information, Location and Competitors

Table 100. Nemaura Pharma Ltd Major Business

Table 101. Nemaura Pharma Ltd Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 102. Nemaura Pharma Ltd SWOT Analysis

Table 103. Nemaura Pharma Ltd Transmucosal Drug Delivery Product and Solutions

Table 104. Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 105. MedPharm LTD Corporate Information, Location and Competitors

Table 106. MedPharm LTD Major Business

Table 107. MedPharm LTD Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 108. MedPharm LTD SWOT Analysis

Table 109. MedPharm LTD Transmucosal Drug Delivery Product and Solutions

Table 110. MedPharm LTD Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 111. tesa Labtec GmbH Transmucosal Drug Delivery Type and Application

Table 112. tesa Labtec GmbH Major Business

Table 113. tesa Labtec GmbH Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 114. tesa Labtec GmbH SWOT Analysis

Table 115. tesa Labtec GmbH Transmucosal Drug Delivery Product and Solutions

Table 116. tesa Labtec GmbH Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 117. Pantec Biosolutions AG Corporate Information, Location and Competitors

Table 118. Pantec Biosolutions AG Major Business

Table 119. Pantec Biosolutions AG Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 120. Pantec Biosolutions AG SWOT Analysis

Table 121. Pantec Biosolutions AG Transmucosal Drug Delivery Product and Solutions

Table 122. Pantec Biosolutions AG Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 123. Mylan, Inc. Corporate Information, Location and Competitors

Table 124. Mylan, Inc. Major Business

Table 125. Mylan, Inc. Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 126. Mylan, Inc. SWOT Analysis

Table 127. Mylan, Inc. Transmucosal Drug Delivery Product and Solutions

Table 128. Mylan, Inc. Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 129. Zosano Pharma Corporate Information, Location and Competitors

Table 130. Zosano Pharma Major Business

Table 131. Zosano Pharma Transmucosal Drug Delivery Total Revenue (USD Million) (2017-2018)

Table 132. Zosano Pharma SWOT Analysis

Table 133. Zosano Pharma Transmucosal Drug Delivery Product and Solutions

Table 134. Zosano Pharma Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 135. Global Transmucosal Drug Delivery Revenue (USD Million) by Players (2015-2020)

Table 136. Global Transmucosal Drug Delivery Revenue Share by Players (2015-2020)

Table 137. Key Players Transmucosal Drug Delivery Revenue (USD Million) in China (2015-2020)

Table 138. Key Players Transmucosal Drug Delivery Revenue Share in China (2015-2020)

Table 139. North America Transmucosal Drug Delivery Revenue (USD Million) by Countries (2015-2020)

Table 140. North America Transmucosal Drug Delivery Revenue Market Share by Countries (2015-2020)

Table 141. North America Transmucosal Drug Delivery Revenue (USD Million) by Countries (2020-2026)

Table 142. North America Transmucosal Drug Delivery Revenue Market Share by Countries (2020-2026)

Table 143. Europe Transmucosal Drug Delivery Revenue (USD Million) by Countries (2015-2020)

Table 144. Europe Transmucosal Drug Delivery Revenue Market Share by Countries (2015-2020)

Table 145. Europe Transmucosal Drug Delivery Revenue (USD Million) by Countries (2020-2026)

Table 146. Europe Transmucosal Drug Delivery Revenue Market Share by Countries (2020-2026)

Table 147. Asia-Pacific Transmucosal Drug Delivery Revenue (USD Million) by Countries (2015-2020)

Table 148. Asia-Pacific Transmucosal Drug Delivery Revenue Market Share by Countries (2015-2020)

Table 149. Asia-Pacific Transmucosal Drug Delivery Revenue (USD Million) by Countries (2020-2026)

Table 150. Asia-Pacific Transmucosal Drug Delivery Revenue Market Share by Countries (2020-2026)

Table 151. South America Transmucosal Drug Delivery Revenue (USD Million) by Countries (2015-2020)

Table 152. South America Transmucosal Drug Delivery Revenue Market Share by Countries (2015-2020)

Table 153. South America Transmucosal Drug Delivery Revenue (USD Million) by Countries (2020-2026)

Table 154. South America Transmucosal Drug Delivery Revenue Market Share by Countries (2020-2026)

Table 155. Middle East & Africa Transmucosal Drug Delivery Revenue (USD Million) by Countries (2015-2020)

Table 156. Middle East & Africa Transmucosal Drug Delivery Revenue Market Share by Countries (2015-2020)

Table 157. Middle East & Africa Transmucosal Drug Delivery Revenue (USD Million) by Countries (2020-2026)

Table 158. Middle East & Africa Transmucosal Drug Delivery Revenue Market Share by Countries (2020-2026)

Table 159. Global Transmucosal Drug Delivery Revenue (USD Million) by Type (2015-2020)

Table 160. Global Transmucosal Drug Delivery Revenue Share by Type (2015-2020)

Table 161. Global Transmucosal Drug Delivery Revenue Forecast by Type (2020-2025)

Table 162. Global Transmucosal Drug Delivery Market Share Forecast by Type (2020-2025)

Table 163. China Transmucosal Drug Delivery Revenue (USD Million) by Type (2015-2020)

Table 164. China Transmucosal Drug Delivery Revenue Share by Type (2015-2020)

Table 165. China Transmucosal Drug Delivery Revenue Forecast by Type (2020-2025)

Table 166. China Transmucosal Drug Delivery Market Share Forecast by Type (2020-2025)

Table 167. Global Transmucosal Drug Delivery Revenue (USD Million) by Application (2015-2020)

Table 168. Global Transmucosal Drug Delivery Revenue Share by Application (2015-2020)

Table 169. Global Transmucosal Drug Delivery Revenue Forecast by Application (2020-2025)

Table 170. Global Transmucosal Drug Delivery Market Share Forecast by Application (2020-2025)

Table 171. China Transmucosal Drug Delivery Revenue (USD Million) by Application (2015-2020)

Table 172. China Transmucosal Drug Delivery Revenue Share by Application (2015-2020)

Table 173. China Transmucosal Drug Delivery Revenue Forecast by Application (2020-2025)

Table 174. China Transmucosal Drug Delivery Market Share Forecast by Application (2020-2025)

List of Figures

Figure 1. Transmucosal Drug Delivery Picture

Figure 2. Global Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 3. Global Transmucosal Drug Delivery Revenue Market Share by Type in 2019

Figure 4. Passive Transdermal Drug Delivery Picture

Figure 5. Active Transdermal Drug Delivery Picture

Figure 6. Transmucosal Drug Delivery Revenue Market Share by Application in 2019

Figure 7. Hospital Picture

Figure 8. Clinic Picture

Figure 9. Others Picture

Figure 10. Global Transmucosal Drug Delivery Revenue and Growth Rate (2015-2025) (USD Million)

Figure 11. Global Transmucosal Drug Delivery Market Size Share by Regions (2015-2025)

Figure 12. Global Transmucosal Drug Delivery Market Size Share by Regions in 2019

Figure 13. Global Transmucosal Drug Delivery Revenue Market Share by Regions (2020-2025)

Figure 14. North America Transmucosal Drug Delivery Revenue (USD Million) and Growth Rate (2015-2025)

Figure 15. Europe Transmucosal Drug Delivery Revenue (USD Million) and Growth Rate (2015-2025)

Figure 16. Asia-Pacific Transmucosal Drug Delivery Revenue (USD Million) and Growth Rate (2015-2025)

Figure 17. South America Transmucosal Drug Delivery Revenue (USD Million) and Growth Rate (2015-2025)

Figure 18. Middle East & Africa Transmucosal Drug Delivery Revenue (USD Million) and Growth Rate (2015-2025)

Figure 19. Global Transmucosal Drug Delivery Revenue Share by Players in 2019

Figure 20. Global Top 5 Players Transmucosal Drug Delivery Revenue Market Share in 2019

Figure 21. Top 10 Players Transmucosal Drug Delivery Revenue Market Share in Global Market in 2019

Figure 22. Global Transmucosal Drug Delivery Market Size (USD Million) by Type (2015-2025)

Figure 23. Global Transmucosal Drug Delivery Market Size Share by Application (2015-2025)

Figure 24. North America Transmucosal Drug Delivery Market Size Share by Countries (2015-2025)

Figure 25. North America Transmucosal Drug Delivery Market Size Share by Countries in 2019

Figure 26. United States Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 27. Canada Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 28. Mexico Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 29. Europe Transmucosal Drug Delivery Market Size Share by Countries (2015-2025)

Figure 30. Europe Transmucosal Drug Delivery Market Size Share by Countries in 2019

Figure 31. Germany Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 32. France Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 33. Russia Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 34. Italy Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 35. Spain Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 36. UK Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 37. Asia Transmucosal Drug Delivery Market Size Share by Countries (2015-2025)

Figure 38. Asia Transmucosal Drug Delivery Market Size Share by Countries in 2019

Figure 39. China Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 40. Japan Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 41. Korea Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 42. India Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 43. Southeast Asia Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 44. South America Transmucosal Drug Delivery Market Size Share by Countries (2015-2025)

Figure 45. South America Transmucosal Drug Delivery Market Size Share by Countries in 2019

Figure 46. Brazil Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 47. Argentina Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 48. Middle East & Africa Transmucosal Drug Delivery Market Size Share by Countries (2015-2025)

Figure 49. Middle East & Africa Transmucosal Drug Delivery Market Size Share by Countries in 2019

Figure 50. Saudi Arabia Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 51. UAE Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 52. Egypt Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 53. South Africa Transmucosal Drug Delivery Market Size (USD Million) and Forecast (2015-2025)

Figure 54. Global Transmucosal Drug Delivery Revenue Share by Type (2015-2020)

Figure 55. China Transmucosal Drug Delivery Revenue Share by Type (2015-2020)

Figure 56. Global Transmucosal Drug Delivery Revenue Share by Application (2015-2020)

Figure 57. China Transmucosal Drug Delivery Revenue Share by Application (2015-2020)